{
  "zip": "94538",
  "sector": "Healthcare",
  "longBusinessSummary": "American BriVision (Holding) Corporation, a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, a combination therapy for triple negative breast cancer; ABV-1504 for major depressive disorders; ABV-1505 for attention deficit hyperactivity disorder; ABV-1703 for the treatment of pancreatic cancer; ABV-1702 to treat myelodysplastic syndromes; and ABV-1601 for treating depression in cancer patients. It has a co-development agreement with Rgene Corporation; collaboration agreement with BioHopeKing Corporation to develop ABV-1501; and collaborative agreement with BioFirst Corporation to co-develop BFC-1401 vitreous substitute for Vitrectom; and license with BioFirst Corporation to research and develop a medical device, ABV-1701 Vitargus for the treatment of retinal detachment or vitreous hemorrhage. The company was founded in 2015 and is based in Fremont, California. American BriVision (Holding) Corporation is a subsidiary of YuanGene Corporation.",
  "city": "Fremont",
  "phone": "845 291 1291",
  "state": "CA",
  "country": "United States",
  "companyOfficers": [],
  "website": "http://www.ambrivis.com",
  "maxAge": 1,
  "address1": "44370 Old Warm Springs Boulevard",
  "industry": "Biotechnology",
  "previousClose": 5.05,
  "regularMarketOpen": 4.85,
  "twoHundredDayAverage": 5.025,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 5,
  "navPrice": null,
  "averageDailyVolume10Day": 1387,
  "totalAssets": null,
  "regularMarketPreviousClose": 5.05,
  "fiftyDayAverage": 5.025,
  "trailingAnnualDividendRate": null,
  "open": 4.85,
  "averageVolume10days": 1387,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 0.311974,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 4.85,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 1300,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 104069504,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 1387,
  "priceToSalesTrailing12Months": 199.82086,
  "dayLow": 4.85,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 1300,
  "fiftyTwoWeekHigh": 5.1,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 4.85,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 5,
  "exchange": "PNK",
  "shortName": "AMERICAN BRIVISION HOLDING CORP",
  "longName": "American BriVision (Holding) Corporation",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "ABVC",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_325748154",
  "uuid": "0f8af6cd-1e3f-33ab-b7e9-bb4a28098e33",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": 206.953,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": -22.752,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 20813900,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": -0.027,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1577750400,
  "heldPercentInstitutions": 0,
  "netIncomeToCommon": -6020552,
  "trailingEps": -0.299,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0.64571,
  "nextFiscalYearEnd": 1640908800,
  "mostRecentQuarter": 1601424000,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": 10199652,
  "enterpriseValue": 107783848,
  "threeYearAverageReturn": null,
  "lastSplitDate": 1557273600,
  "lastSplitFactor": "1:18",
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 4.85,
  "logo_url": "https://logo.clearbit.com/ambrivis.com"
}